Lotus Eye Hospital and Institute Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Lotus Eye Hospital and Institute.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 26.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lotus Eye Hospital and Institute has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 485 | 22 | N/A | N/A | N/A |
| 3/31/2024 | 482 | 29 | 0 | 57 | N/A |
| 12/31/2023 | 485 | 35 | N/A | N/A | N/A |
| 9/30/2023 | 486 | 40 | -1 | 57 | N/A |
| 6/30/2023 | 477 | 41 | N/A | N/A | N/A |
| 3/31/2023 | 470 | 41 | 13 | 44 | N/A |
| 12/31/2022 | 464 | 40 | N/A | N/A | N/A |
| 9/30/2022 | 459 | 42 | 13 | 69 | N/A |
| 6/30/2022 | 449 | 46 | N/A | N/A | N/A |
| 3/31/2022 | 389 | 30 | -3 | 44 | N/A |
| 12/31/2021 | 389 | 36 | N/A | N/A | N/A |
| 9/30/2021 | 372 | 32 | 37 | 49 | N/A |
| 6/30/2021 | 335 | 20 | N/A | N/A | N/A |
| 3/31/2021 | 324 | 16 | 23 | 27 | N/A |
| 12/31/2020 | 300 | -5 | N/A | N/A | N/A |
| 9/30/2020 | 301 | -14 | 8 | 26 | N/A |
| 6/30/2020 | 335 | -6 | N/A | N/A | N/A |
| 3/31/2020 | 406 | 11 | 26 | 50 | N/A |
| 12/31/2019 | 420 | 21 | N/A | N/A | N/A |
| 9/30/2019 | 415 | 20 | N/A | N/A | N/A |
| 6/30/2019 | 401 | 11 | N/A | N/A | N/A |
| 3/31/2019 | 384 | 7 | -5 | 42 | N/A |
| 12/31/2018 | 382 | 7 | N/A | N/A | N/A |
| 9/30/2018 | 381 | 9 | N/A | N/A | N/A |
| 6/30/2018 | 384 | 14 | N/A | N/A | N/A |
| 3/31/2018 | 380 | 17 | N/A | 58 | N/A |
| 12/31/2017 | 373 | 8 | N/A | N/A | N/A |
| 9/30/2017 | 359 | 4 | N/A | N/A | N/A |
| 6/30/2017 | 350 | 6 | N/A | N/A | N/A |
| 3/31/2017 | 340 | 4 | N/A | 30 | N/A |
| 12/31/2016 | 330 | 7 | N/A | N/A | N/A |
| 9/30/2016 | 324 | 7 | N/A | N/A | N/A |
| 6/30/2016 | 314 | 0 | N/A | N/A | N/A |
| 3/31/2016 | 311 | 1 | N/A | 34 | N/A |
| 12/31/2015 | 311 | -5 | N/A | N/A | N/A |
| 9/30/2015 | 315 | -6 | N/A | N/A | N/A |
| 6/30/2015 | 308 | -14 | N/A | N/A | N/A |
| 3/31/2015 | 302 | -20 | N/A | 24 | N/A |
| 12/31/2014 | 298 | -12 | N/A | N/A | N/A |
| 9/30/2014 | 290 | -9 | N/A | N/A | N/A |
| 6/30/2014 | 289 | 1 | N/A | N/A | N/A |
| 3/31/2014 | 288 | 0 | N/A | 44 | N/A |
| 12/31/2013 | 287 | 4 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if LOTUSEYE's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if LOTUSEYE's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if LOTUSEYE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if LOTUSEYE's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if LOTUSEYE's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LOTUSEYE's Return on Equity is forecast to be high in 3 years time